Article Details
Retrieved on: 2018-03-11 00:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Massachusetts-based Rhumbline Advisers has invested 0% in Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX). Aqr Capital Mngmt Limited Liability stated it has 0% of its portfolio in Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX). 25.79 million are owned by <b>Baupost Group</b> Inc Limited Liability Ma.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here